NCT03475693View on ClinicalTrials.gov

A Cohort Study Evaluating the Efficacy of PO Magnesium in the Treatment of Acute Traumatic Brain Injury in Adolescents

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

November 30, 2019

Study Completion Date

December 30, 2019

Conditions
Concussion Post Syndrome
Interventions
DRUG

Magnesium Oxide

400 mg Magnesium oxide tablet given once in the ED, and prescribed to take BID for 5 days total after discharge

DRUG

Acetaminophen

500 mg tablets given once in the ED, and prescribed to take BID for 5 days total after discharge.

DRUG

Zofran ODT 4 MG Disintegrating Oral Tablet

Given once in the Emergency department

Trial Locations (1)

49085

Lakeland Regional Healthcare, Saint Joseph

All Listed Sponsors
collaborator

Michigan State University

OTHER

lead

Spectrum Health - Lakeland

OTHER

NCT03475693 - A Cohort Study Evaluating the Efficacy of PO Magnesium in the Treatment of Acute Traumatic Brain Injury in Adolescents | Biotech Hunter | Biotech Hunter